After the #EULAR2022 Recommendations session, it begs the question - Do we follow it? In Germany, the answer is sometimes Early bDMARD or JAKi is more frequent in recent years. 1/3 of patients did not receive recommended treatment escalation after 1st csDMARD POS0234 @Rheumnow https://t.co/0DaP5b7Htc

Real-world data: #SLE Rx & pt willingness to take risk: 342 pts w/SLE surveyed on hypothetical Rx's based on Sx's. Pts value Sx improvement more than risks & rated most➡️least important: joint pain, rash, & fatigue, risk for infx was least impt #EULAR2022 @Rheumnow POS0086-PARE

#EULAR2022 Update ANCA-associated vasculitis ⭐️Last update 2016 ▶️Tissue bx important! ▶️RTX for most for remission, maintenance ▶️Lower steroids (50-75 mg, decrease to 5 mg/d by 4-5 mo), can use avacopan to ⬇️ ▶️ No routine PLEX ▶️Maintenance is 24-48 mo, tailor to pt @RheumNow https://t.co/OmCne2lIIb

#EULAR2022 EGPA recommendations: Organ or life-threatening? Y = CYC, N = steroid Relapsing disease? Mepolizumab @Rheumnow https://t.co/qh564cAhC2

#EULAR2022 AAV Reccs summarized for induction remission for GPA/MPA @rheumnow https://t.co/Cbp72bCcik

Do you use PJP prophylaxis on patients with ANCA vasculitis on rituximab without high dose steroids? #EULAR2022 ANCA-associated recommendations @RheumNow

#EULAR2022 AAV Reccs for Steroids: start prednisone 50-75 mg/d prednisone and taper to goal 5 mg/day by 4-5 months based on #PEXIVAS @rheumnow https://t.co/6gIfme4HXH

Overarching principles of #EULAR2022 Ax Spa Updated Reccs @Rheumnow https://t.co/g6Hd9NE1vB

#EULAR2022 updated ASAS-EULAR guidelines for the management of axSpA review with Dr. @sofiaramiro82 @RheumNow https://t.co/SHg4y49auA

#EULAR2022 ASAS Updated Reccs: Treatment Algorithm @rheumnow https://t.co/YEdhrAX0lT

#EULAR2022 ASAS-EULAR guidelines for axSpA with Dr. @sofiaramiro82. Below are the recommendations including b/tsDMARDs. If ASDAS > 2.1 the recommendations call for consideration for TNFi, IL17i, or JAKi. Re-evaluate after at least 12 weeks on tx and for co-morbidities. @RheumNow https://t.co/mryL3YmtzN

Dr. @sofiaramiro82 important conclusion considerations from the ASAS-EULAR guidelines for axSpa. @RheumNow #EULAR2022 https://t.co/7Q3zxo7euj

Nice session (joint chaired @AurelieRheumo) on AI in rheumatology - particularly from Michael Barnes on deciphering the polyome. It's a whole door opened with insights beyond, but some careful steps necessary first (& cross-disciplinary footsteps to follow) #EULAR2022 @RheumNow https://t.co/vLfDvcEnxo

#EULAR2022 RA Recommendations ⭐️Last update 2019 ▶️GC use when starting csDMARD - but taper and STOPPED asap. 🔔This contrasts with ACR2021 rec to avoid GC ▶️JAKi no longer equal to bDMARDs, consider usage with risk assessment @RheumNow https://t.co/fotMgdrFop

What is the wait period for a patient to see a rheumatologist in your country? Danish laws mandates the wait for a rheumatologist cannot be longer than 4 weeks (either by telemedicine or in person appts). #EULAR2022 @rheumnow https://t.co/TaYysIyGSi